ecropolis

Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine A Prespecified Secondary Analysis of the Randomized DANFLU-2 Trial |

Three Pharmaceutical Companies Announce U.S. FDA Approval for Updated COVID. The U.S. FDA’s Center for Biologics Evaluation and Research has suspended the biologics license for Valneva Austria GmbH’s live – attenuated IXCHIQ vaccine.

Ivermectin to Control Malaria — A Cluster-Randomized Trial | Relative Effectiveness of High-dose versus Standard-dose Influenza Vaccine against Hospitalizations and Mortality According to Frailty Score: A Post-hoc Analysis of the DANFLU-1 Randomized Trial

Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated with Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years |

Influenza With and Without Oseltamivir Treatment and Neuropsychiatric Events Among Children and Adolescents | Effectiveness of the BNT162b2 and mRNA-1273 JN.1-adapted Vaccines against COVID-19-associated Hospitalisation and Death: A Danish, Nationwide, Register-based, Cohort Study | Hospitalization for COVID-19 and Risk Factors for Severe Disease Among Children: 2022–2024

Effects of Baloxavir Marboxil Plus Neuraminidase Inhibitor versus Neuraminidase Inhibitor in High-risk Patients Hospitalized with Severe Influenza: A Post Hoc Analysis of the Flagstone Trial | Safety of JN.1-Updated mRNA COVID-19 Vaccines | Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients

Respiratory Syncytial virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis | Real-world Evaluation of the Effectiveness of Sinopharm COVID-19 Vaccine Against Symptomatic COVID-19 in an Omicron-Dominant Setting in Mozambique: A Test-Negative, Case-Control Study | Utility of Glucagon-Like-Peptide-1-Receptor Agonists in Mast Cell Activation Syndrome

The Impact of Highly Pathogenic Avian Influenza H5N1 Virus Infection on Dairy Cows | Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce | Drug Treatments for Mild or Moderate Covid-19: Systematic Review and Network Meta-analysis

Lower Risk of Dementia with AS01-Adjuvanted Vaccination against Shingles and Respiratory Syncytial Virus Infections | Influenza Vaccination Reduces Dementia risk: A Systematic Review and Meta-analysis | Association of SARS-CoV-2 With Health-related Quality of Life 1 Year After Illness Using Latent Transition Analysis